Welcome to our dedicated page for Life360 SEC filings (Ticker: LIFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Life360's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Life360's regulatory disclosures and financial reporting.
Lauren Antonoff filed a Form 144 reporting the intent to sell 2,716 shares of Common Stock on 04/16/2026 tied to Restricted Stock Vesting. The filing lists a broker at Fidelity Brokerage Services LLC.
The Form also records prior dispositions of 17,153 shares sold on 03/06/2026 for $769,490.44. All amounts and dates are those shown in the excerpt.
Lauren Antonoff filed a Form 144 reporting the intent to sell 2,716 shares of Common Stock on 04/16/2026 tied to Restricted Stock Vesting. The filing lists a broker at Fidelity Brokerage Services LLC.
The Form also records prior dispositions of 17,153 shares sold on 03/06/2026 for $769,490.44. All amounts and dates are those shown in the excerpt.
Burke Russell John reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc.’s Chief Financial Officer Russell John Burke reported a grant of 43,416 restricted stock units (RSUs), each representing a right to receive one share of common stock upon settlement. The RSUs vest in equal monthly installments, with 1/48th vesting each month starting on January 1, 2026, subject to his continued service.
Following this grant, he holds 124,254 RSUs directly and also has an indirect holding of 113,361 shares of common stock through revocable trusts. This filing reflects compensation-related equity awards rather than open‑market share purchases or sales.
Burke Russell John reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc.’s Chief Financial Officer Russell John Burke reported a grant of 43,416 restricted stock units (RSUs), each representing a right to receive one share of common stock upon settlement. The RSUs vest in equal monthly installments, with 1/48th vesting each month starting on January 1, 2026, subject to his continued service.
Following this grant, he holds 124,254 RSUs directly and also has an indirect holding of 113,361 shares of common stock through revocable trusts. This filing reflects compensation-related equity awards rather than open‑market share purchases or sales.
Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at $11.18 per share and then sold 7,930 shares at $37.27 per share on the same day. The filing shows he directly holds 105,456 common shares afterward, which include 679 restricted stock units previously granted. The stock option exercised was fully vested and exercisable and is now fully used. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at $11.18 per share and then sold 7,930 shares at $37.27 per share on the same day. The filing shows he directly holds 105,456 common shares afterward, which include 679 restricted stock units previously granted. The stock option exercised was fully vested and exercisable and is now fully used. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
Life360, Inc. amendment filed a Schedule 13G/A reporting that Hyperion Asset Management Limited beneficially owned 5,471,445 shares of Life360 common stock, representing 6.98% of the class as shown for the period ending 03/31/2026. The filing lists sole voting and dispositive power over the reported shares.
Life360, Inc. amendment filed a Schedule 13G/A reporting that Hyperion Asset Management Limited beneficially owned 5,471,445 shares of Life360 common stock, representing 6.98% of the class as shown for the period ending 03/31/2026. The filing lists sole voting and dispositive power over the reported shares.
Charles Prober reported a proposed sale of 7,930 shares of Common Stock under Rule 144, dated 04/13/2026. The filing notes an option granted on 04/12/2022 and lists prior dispositions in the three months before the filing: 7,930 shares sold on 01/13/2026 for $491,501.40, 7,930 shares sold on 02/13/2026 for $388,728.60, and 7,930 shares sold on 03/13/2026 for $328,302.00. The broker entry for 04/13/2026 shows Fidelity Brokerage Services LLC and an amount of $295,551.10.
Charles Prober reported a proposed sale of 7,930 shares of Common Stock under Rule 144, dated 04/13/2026. The filing notes an option granted on 04/12/2022 and lists prior dispositions in the three months before the filing: 7,930 shares sold on 01/13/2026 for $491,501.40, 7,930 shares sold on 02/13/2026 for $388,728.60, and 7,930 shares sold on 03/13/2026 for $328,302.00. The broker entry for 04/13/2026 shows Fidelity Brokerage Services LLC and an amount of $295,551.10.
Life360, Inc. director John Philip Coghlan reported an open-market sale of 4,000 shares of common stock at a weighted average price of $41.32 per share. The shares were sold by the John Coghlan Living Trust under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025.
After this sale, the John Coghlan Living Trust held 36,431 shares of Life360 common stock. Separate from the trust, Coghlan also reported 836 restricted stock units directly and 55,494 shares held indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
Life360, Inc. director John Philip Coghlan reported an open-market sale of 4,000 shares of common stock at a weighted average price of $41.32 per share. The shares were sold by the John Coghlan Living Trust under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025.
After this sale, the John Coghlan Living Trust held 36,431 shares of Life360 common stock. Separate from the trust, Coghlan also reported 836 restricted stock units directly and 55,494 shares held indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
Life360 director Alex Haro exercised stock options to acquire additional common shares. He exercised options covering 144,533 shares of Life360, Inc. common stock across three grants at exercise prices of $2.15, $8.19 and $13.35 per share. These exercises converted derivative awards into outright share ownership and left no remaining balance in the exercised option grants. Following the transactions, Haro directly owned 1,005,848 shares of common stock. This direct position includes 679 restricted stock units, each representing a right to receive one share of common stock upon vesting.
Life360 director Alex Haro exercised stock options to acquire additional common shares. He exercised options covering 144,533 shares of Life360, Inc. common stock across three grants at exercise prices of $2.15, $8.19 and $13.35 per share. These exercises converted derivative awards into outright share ownership and left no remaining balance in the exercised option grants. Following the transactions, Haro directly owned 1,005,848 shares of common stock. This direct position includes 679 restricted stock units, each representing a right to receive one share of common stock upon vesting.
Life360, Inc. Chief Financial Officer Russell John Burke reported an equity award linked to performance-based restricted stock units. On March 25, 2026, a performance metric tied to PRSUs granted on April 9, 2025 was determined to be satisfied, triggering acquisition of 24,265 shares of common stock at no cost.
Each PRSU represents a right to receive one share upon settlement. According to the filing, 25% of these PRSUs vested on January 1, 2026, with the remaining 75% converted to time-based RSUs that will vest in twelve equal quarterly installments, subject to continued service. Following this and prior grants, Burke holds 80,838 restricted stock units directly and 113,361 shares indirectly through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust ELD as tenants in common, reflecting both direct and trust-based ownership. The filing also notes an exempt transfer of 22,284 directly held shares into this trust structure.
Life360, Inc. Chief Financial Officer Russell John Burke reported an equity award linked to performance-based restricted stock units. On March 25, 2026, a performance metric tied to PRSUs granted on April 9, 2025 was determined to be satisfied, triggering acquisition of 24,265 shares of common stock at no cost.
Each PRSU represents a right to receive one share upon settlement. According to the filing, 25% of these PRSUs vested on January 1, 2026, with the remaining 75% converted to time-based RSUs that will vest in twelve equal quarterly installments, subject to continued service. Following this and prior grants, Burke holds 80,838 restricted stock units directly and 113,361 shares indirectly through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust ELD as tenants in common, reflecting both direct and trust-based ownership. The filing also notes an exempt transfer of 22,284 directly held shares into this trust structure.
Life360, Inc. Chief Executive Officer Lauren Antonoff reported an equity award tied to performance. She acquired 24,265 shares of common stock at no cost through performance-based restricted stock units after a performance metric was met. Following this grant, she directly holds 312,497 shares, including earlier restricted stock unit awards.
Life360, Inc. Chief Executive Officer Lauren Antonoff reported an equity award tied to performance. She acquired 24,265 shares of common stock at no cost through performance-based restricted stock units after a performance metric was met. Following this grant, she directly holds 312,497 shares, including earlier restricted stock unit awards.
Life360 Inc — The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A disclosing that, after an internal realignment, the reporting parties formerly aggregated with Vanguard now report separately and the filing shows 0 shares beneficially owned and 0% of the class.
The amendment cites SEC Release No. 34-39538 (January 12, 1998) and states the holdings are reported in the form of depository receipts. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Life360 Inc — The Vanguard Group filed Amendment No. 5 to a Schedule 13G/A disclosing that, after an internal realignment, the reporting parties formerly aggregated with Vanguard now report separately and the filing shows 0 shares beneficially owned and 0% of the class.
The amendment cites SEC Release No. 34-39538 (January 12, 1998) and states the holdings are reported in the form of depository receipts. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.